Authors


Gary Ritchie

Latest:

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.


Robert Popilock

Latest:

Using Gas Headspace Analysis to Assess Glass and Nontraditional Vial-Closure Integrity

Increased use of nested and ready-to-use primary packaging has resulted in a need for more validation data on container-closure integrity. This article describes efforts to develop these data for new and traditional containers and closures.


Amy R. Barker

Latest:

Restructuring Method Transfer Through Global Sites

Method-transfer kits help simplify analytical method transfer for global site certifications.


Arvindh Balakrishnan

Latest:

ePedigree: Using the Gift of Time Wisely

The year 2011 may seem far off, but there is much to do to prepare for electronic pedigrees.


Amanda Guiraldelli

Latest:

Evolution of Analytical Procedure Validation Concepts: Part II– Incorporation of Science and Risk-based Principles in ICH Q14 and Q2(R2) Guidelines

This article focuses on drawing parallels between ICH Q14/Q2(R2), United States Pharmacopeia (USP) <1220>, and International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017.


Guenter Brenn 

Latest:

Printable Medicines: A Microdosing Device For Producing Personalized Medicines

The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.


Tamie Joeckel

Latest:

Challenges of Expanding CAR-T Cell Therapy into Solid Tumors

The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.



Supriyadi Hafiz

Latest:

Seven Trends Shaping the Future of Pharmaceutical Formulation Development

Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.




William Hauck

Latest:

QMM for Pharmaceutical Manufacturers– Implications for Drug Manufacturers, API Suppliers and Contract Manufacturers

QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.


Jason Boyd

Latest:

Getting Lab Data Closer to the Decision Point Keeps Product Release on Track

Using one system for test execution and sample management, improving right-first-time, and allowing review by exception can deliver access to key lab data faster.


Cecil Nick

Latest:

Clinical And Cost Considerations Of Developing A Biosimilar

Both biosimilar and generic drugs have an abbreviated approval process; however, the clinical trial requirements differ enormously.


Courtney LeBlon

Latest:

Contamination Control for Cell and Gene Therapies Needs New Analytics

Analytical methods need a boost to ensure quality control for cell and gene therapies.



S. Kundu

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


Simtra BioPharma Solutions

Latest:

Talking Strategic Development with Simtra at DCAT

Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence.


Jean-Marc Roussel

Latest:

Ongoing Analytical Procedure Performance Verification—Stage 3 of USP<1220>

Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.


Kevin ODonnell

Latest:

QRM, Knowledge Management, and the Importance of ICH Q9(R1)

This paper reflects upon the past 15 years of experience in the application of QRM and KM within the pharmaceutical GMP environment.


Natoli Scientific

Latest:

Application of machine learning tools for predicting impact of punch cup depth on tablet capping

We have proposed a comprehensive capping index parameter which is a ratio of compact anisotropic index to material anisotropic index. This study will help to design or select right tooling for successful tablet manufacturing.


Reginaldo A. Saraceno

Latest:

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.


Frederic Menardo

Latest:

EU Anti-Counterfeiting Legislation On Its Way

In order to combat the threat of counterfeits in Europe, the EU's current anti-counterfeiting directive is being amended.


Kari Miller

Latest:

Revitalizing Quality Management Processes through Digitalization

Eradicating paper-based workflows and standalone solutions operating in isolation provides a good starting point to update quality management processes.


A. V. Mamishev

Latest:

Dielectric Spectroscopy: Choosing the Right Approach

This tutorial paper is meant to aid in dielectric-sensor selection


Stephan Hütter

Latest:

The Next Frontier in Pharmaceutical Outsourcing

While companies today outsource numerous processes, from early development through to manufacturing, there are still many opportunities to realize the full potential of outsourcing services.


Brian Cheng

Latest:

Coating and Taste Masking with Shellac

The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.


Norman Richardson

Latest:

Evaluating the Impact of Fatty Alcohols on Permeation of Clotrimazole from Topical Creams

Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.


David Wolton

Latest:

Using Robotics in the Aseptic Manufacturing Facility of the Future

Several steps need be taken to achieve lights-out, fully automated operations.


Gail Reed

Latest:

Specification Equivalence—A Practical Approach

In this first of a four-part series, the authors provide an introduction to a practical approach for establishing specification equivalence. The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process.